Toll-like receptor 7 and Toll-like receptor 9 agonists effectively enhance immunological memory in Plasmodium chabaudi infected BALB/c mice

被引：3
|
作者：
Gao, Wenyan [1 ,2 ]
Sun, Xiaodan [1 ]
Li, Danni [1 ]
Sun, Lin [1 ]
He, Yang [1 ]
Wei, Huanping [1 ]
Jin, Feng [3 ]
Cao, Yaming [1 ]
机构：
[1] China Med Univ, Dept Immunol, Basic Med Coll, Shenyang 110122, Liaoning, Peoples R China
[2] China Med Univ, Dept Obstet, Hosp 1, Shenyang 110001, Liaoning, Peoples R China
[3] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang 110001, Liaoning, Peoples R China
来源：
INTERNATIONAL IMMUNOPHARMACOLOGY | 2020年 / 81卷
基金：
中国国家自然科学基金;
关键词：
PROTECTIVE IMMUNITY; CELL RESPONSES; B-CELLS; DIFFERENTIATION; FALCIPARUM; VACCINES; MALARIA; IMMUNOGENICITY; ADJUVANTS; ANTIBODY;
D O I：
10.1016/j.intimp.2020.106248
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页数：8
相关论文
共 50 条
  • [21] Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model
    Ma, Yifan
    Poisson, Louis
    Sanchez-Schmitz, Guzman
    Pawar, Santosh
    Qu, Chunfeng
    Randolph, Gwendalyn J.
    Warren, William L.
    Mishkin, Eric M.
    Higbee, Russell G.
    IMMUNOLOGY, 2010, 130 (03) : 374 - 387
  • [22] Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism
    Ngoc Lan Tran
    Manzin-Lorenzi, Celine
    Santiago-Raber, Marie-Laure
    IMMUNOLOGY, 2015, 145 (01) : 60 - 70
  • [23] Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands
    Hussein, Waleed M.
    Choi, Phil M.
    Zhang, Cheng
    Su, Mei
    Sierecki, Emma
    Johnston, Wayne
    Fagan, Vincent
    Alexandrov, Kirill
    Skwarczynski, Mariusz
    Gambin, Yann
    Toth, Istvan
    Simerska, Pavla
    CURRENT DRUG DELIVERY, 2017, 14 (07) : 935 - 943
  • [24] Epicutaneous Application of Toll-like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild-Type Mice
    Yokogawa, Maki
    Takaishi, Mikiro
    Nakajima, Kimiko
    Kamijima, Reiko
    Fujimoto, Chisa
    Kataoka, Sayo
    Terada, Yoshio
    Sano, Shigetoshi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (03) : 694 - 706
  • [25] Toll-Like Receptor 7 Mediates Early Innate Immune Responses to Malaria
    Baccarella, Alyssa
    Fontana, Mary F.
    Chen, Eunice C.
    Kim, Charles C.
    INFECTION AND IMMUNITY, 2013, 81 (12) : 4431 - 4442
  • [26] Coevolutionary Analysis Implicates Toll-Like Receptor 9 in Papillomavirus Restriction
    King, Kelly
    Larsen, Brendan B.
    Gryseels, Sophie
    Richet, Cecile
    Kraberger, Simona
    Jackson, Robert
    Worobey, Michael
    Harrison, Joseph S.
    Varsani, Arvind
    Van Doorslaer, Koenraad
    MBIO, 2022, 13 (02):
  • [27] IgE Inhibits Toll-like Receptor 7-and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
    Khoryati, Liliane
    Augusto, Jean-Francois
    Shipley, Emilie
    Contin-Bordes, Cecile
    Douchet, Isabelle
    Mitrovic, Stephane
    Truchetet, Marie-Elise
    Lazaro, Estibaliz
    Duffau, Pierre
    Couzi, Lionel
    Jacquemin, Clement
    Barnetche, Thomas
    Vacher, Pierre
    Schaeverbeke, Thierry
    Blanco, Patrick
    Richez, Christophe
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (09) : 2221 - 2231
  • [28] Trial watch: Toll-like receptor ligands in cancer therapy
    Le Naour, Julie
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [29] Toll-like receptor bioactivity in endothelial progenitor cells
    Heidarzadeh, Morteza
    Roodbari, Fatemeh
    Hassanpour, Mehdi
    Ahmadi, Mahdi
    Saberianpour, Shirin
    Rahbarghazi, Reza
    CELL AND TISSUE RESEARCH, 2020, 379 (02) : 223 - 230
  • [30] Toll-like receptor 2 and type 2 diabetes
    Sepehri, Zahra
    Kiani, Zohre
    Nasiri, Ali Akbar
    Kohan, Farhad
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2016, 21
12345